Mystic Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Sell
12,425
-375
-3% -$17.8K 0.11% 150
2025
Q4
$651K Buy
12,800
+350
+3% +$17.9K 0.15% 120
2025
Q3
$691K Buy
12,450
+25
+0.2% +$1.46K 0.16% 120
2025
Q2
$858K Sell
12,425
-660
-5% -$44.9K 0.21% 104
2025
Q1
$909K Sell
13,085
-100
-0.8% -$8.26K 0.24% 96
2024
Q4
$1.13M Buy
13,185
+150
+1% +$16.2K 0.3% 83
2024
Q3
$1.55M Sell
13,035
-1,150
-8% -$153K 0.59% 56
2024
Q2
$2.02M Sell
14,185
-795
-5% -$105K 0.82% 36
2024
Q1
$1.92M Buy
14,980
+1,655
+12% +$197K 0.8% 39
2023
Q4
$1.38M Sell
13,325
-730
-5% -$72.2K 0.66% 48
2023
Q3
$1.28M Sell
14,055
-425
-3% -$37.4K 0.72% 41
2023
Q2
$1.17M Sell
14,480
-1,030
-7% -$84.1K 0.63% 51
2023
Q1
$1.23M Sell
15,510
-300
-2% -$21.3K 0.68% 47
2022
Q4
$1.07M Sell
15,810
-250
-2% -$14.7K 0.61% 61
2022
Q3
$800K Hold
16,060
0.51% 65
2022
Q2
$894K Sell
16,060
-540
-3% -$30K 0.55% 65
2022
Q1
$921K Sell
16,600
-100
-0.6% -$5.13K 0.5% 68
2021
Q4
$935K Buy
+16,700
New +$905K 0.44% 70

Other funds holding NVO

Mystic Asset Management's NVO Position: Q1 2026 in Review

Mystic Asset Management reduced its Novo Nordisk (NVO) stake by 2.9% in Q1 2026, selling an estimated $17.8K and leaving 12,425 shares worth $457K. The position accounts for 0.11% of the portfolio, ranked #150.

Mystic Asset Management first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.02M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Mystic Asset Management held 12,425 shares of Novo Nordisk worth $457K as of Q1 2026.
  • Mystic Asset Management sold 375 Novo Nordisk shares in Q1 2026, an estimated $17.8K.
  • Novo Nordisk made up 0.11% of Mystic Asset Management's portfolio in Q1 2026, its #150 holding.
  • Mystic Asset Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • Mystic Asset Management's Novo Nordisk position peaked at $2.02M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.